investigator_user
investigator
user
funding
collaborators
pending
menu
bell
message
arrow_up
arrow_down
filter
layers
globe
marker
add
arrow
close
download
edit
facebook
info
linkedin
minus
plus
save
share
search
sort
twitter
remove
user-plus
user-minus
Sign Up for Updates
Map
Countries
Cancer types
All cancers but non-melanoma skin cancer
Bladder
Brain, nervous system
Breast
Cervix uteri
Colorectum
Corpus uteri
Gallbladder
Hodgkin lymphoma
Kaposi sarcoma
Kidney, renal pelvis and ureter
Larynx
Leukaemia
Lip, oral cavity
Liver and intrahepatic bile ducts
Melanoma of skin
Multiple myeloma and immunoproliferative diseases
Nasopharynx
Non-Hodgkin lymphoma
Non-Melanoma skin cancer
Oesophagus
Other pharynx
Ovary
Pancreas
Prostate
Sarcoma
Stomach
Testis
Thymus
Thyroid
Trachea, bronchus and lung
Specialities
Hematology and hematologic malignancies
Palliative Care
Pathology
Pediatric oncology or childhood cancer
Radiation Oncology
Surgery / Surgical oncology
Blog
About
Login
Project leads
Collaborators
Development of Novel Agents Active against Hepatitis B Virus
Hiroaki Mitsuya
5 Collaborator(s)
Funding source
National Cancer Institute (NIH)
Follow
+ Project
+ Post
+ Event
Info
People
Posts
Hiroyuki Hayakawa
Yamasa Corporation (Japan)
Chiba, Japan
Yasuhito Tanaka
Nagoya City University
Nagoya, Japan
Masayuki Amano
Kumamoto University
Kumamoto, Japan
Manabu Aoki
Kumamoto University
Kumamoto, Japan
Hiromi Ogata-Aoki
Kumamoto University
Kumamoto, Japan
Hiroaki Mitsuya
National Cancer Institute (NIH)
Rockville, United States
Related projects
Robert G Roeder
Transcriptional Regulatory Mechanisms in B Cell Development and Leukemogenesis
Leukaemia
Pathology
Alan Rein
Retrovirus Assembly And Maturation
Leukaemia
Pathology
Daniel G Tenen
Mechanisms of regulation by RNA in acute myeloid leukemia
Leukaemia
Pathology
Danilo Perrotti
Role of microRNAs in the Regulation of CML Stem Cell Self Renewal and Survival
Leukaemia
Pathology
Monica J Justice
The Pluripotency Regulator Prdm14 Initiates Cancer by Epigenetic Mechanisms
Leukaemia
Pathology
Daniel McVicar
Characterization of the Expression and Ligands of KIR3DS2
Leukaemia
Pathology
Paul J Brindley
Role of Liver Fluke Granulin in Cholangiocarcinogenesis
Liver and intrahepatic bile ducts
Pathology
Bruce R Blazar
Cytotoxic-T-Lymphocyte (CTL) Therapy of Acute Myeloid Leukemia (AML)
Leukaemia
Pathology
Ju-Seog Lee
Validation of Prognostic Markers in Advanced Hepatocellular Carcinoma and Identification of Potention Serological Prognostic Markers
Liver and intrahepatic bile ducts
Pathology
